Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Measles Immunity in Adult Allo-HSCT Recipients
NCT05947864Recruiting
- Sponsor
- Hospices Civils de Lyon
- Start
- Aug 2023
- Primary completion
- Jul 2025
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Open-label trial of measles, mumps, and rubella vaccine in measles, mumps and rubella (2 arms), sponsored by Hospices Civils de Lyon. Primary endpoint: Combined quantification of measles-specific markers of T-cell-mediated immunity and B-cell-mediated immunity at Day 1. Started Aug 2023; status: recruiting.
02
Drugs
measles, mumps, and rubella vaccine
03
Conditions
measlesmumpsrubella
Beyond the preview
Go deeper on NCT05947864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05947864.